Jong-Won Chung1, Oh Young Bang2, Kangmo Ahn1, Sang-Soon Park1, Tai Hwan Park1, Jae Guk Kim1, Youngchai Ko1, SooJoo Lee1, Kyung Bok Lee1, Jun Lee1, Kyusik Kang1, Jong-Moo Park1, Yong-Jin Cho1, Keun-Sik Hong1, Hyun-Wook Nah1, Dae-Hyun Kim1, Jae-Kwan Cha1, Wi-Sun Ryu1, Dong-Eog Kim1, Joon-Tae Kim1, Jay Chol Choi1, Mi-Sun Oh1, Kyung-Ho Yu1, Byung-Chul Lee1, Ji Sung Lee1, Juneyoung Lee1, Hong-Kyun Park1, Beom Joon Kim1, Moon-Ku Han1, Hee-Joon Bae2. 1. From the Department of Neurology (J.-W.C., O.Y.B.), Department of Pediatrics, Environmental Health Center for Atopic Diseases (K.A.), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Neurology, Seoul Medical Center, Seoul, Republic of Korea (S.-S.P., T.H.P.); Department of Neurology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Republic of Korea (J.G.K., Y.K., S.L.); Department of Neurology, Soonchunhyang University College of Medicine, Seoul, Republic of Korea (K.B.L.); Department of Neurology, Yeungnam University Hospital, Daegu, Republic of Korea (Jun Lee); Department of Neurology, Eulji General Hospital, Eulji University, Seoul, Republic of Korea (K.K., J.-M.P.); Department of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Republic of Korea (Y.-J.C., K.-S.H.); Department of Neurology, Dong-A University Hospital, Pusan, Republic of Korea (H.-W.N., D.-H.K., J.-K.C.); Department of Neurology, Dongguk University Ilsan Hospital, Goyang, Republic of Korea (W.-S.R., D.-E.K.); Department of Neurology, Chonnam National University Hospital, Gwangju, Republic of Korea (J.-T.K.); Department of Neurology, Jeju National University Hospital, Jeju National University School of Medicine, Republic of Korea (J.C.C.); Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea (M.-S.O., K.-H.Y., B.-C.L.); Clinical Research Center, Asan Medical Center, Seoul, Republic of Korea (J.S.L.); Department of Biostatistics, Korea University College of Medicine, Seoul, Republic of Korea (Juneyoung Lee); and Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea (H.-K.P., B.J.K., M.-K.H., H.-J.B.). 2. From the Department of Neurology (J.-W.C., O.Y.B.), Department of Pediatrics, Environmental Health Center for Atopic Diseases (K.A.), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Neurology, Seoul Medical Center, Seoul, Republic of Korea (S.-S.P., T.H.P.); Department of Neurology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Republic of Korea (J.G.K., Y.K., S.L.); Department of Neurology, Soonchunhyang University College of Medicine, Seoul, Republic of Korea (K.B.L.); Department of Neurology, Yeungnam University Hospital, Daegu, Republic of Korea (Jun Lee); Department of Neurology, Eulji General Hospital, Eulji University, Seoul, Republic of Korea (K.K., J.-M.P.); Department of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Republic of Korea (Y.-J.C., K.-S.H.); Department of Neurology, Dong-A University Hospital, Pusan, Republic of Korea (H.-W.N., D.-H.K., J.-K.C.); Department of Neurology, Dongguk University Ilsan Hospital, Goyang, Republic of Korea (W.-S.R., D.-E.K.); Department of Neurology, Chonnam National University Hospital, Gwangju, Republic of Korea (J.-T.K.); Department of Neurology, Jeju National University Hospital, Jeju National University School of Medicine, Republic of Korea (J.C.C.); Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea (M.-S.O., K.-H.Y., B.-C.L.); Clinical Research Center, Asan Medical Center, Seoul, Republic of Korea (J.S.L.); Department of Biostatistics, Korea University College of Medicine, Seoul, Republic of Korea (Juneyoung Lee); and Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea (H.-K.P., B.J.K., M.-K.H., H.-J.B.). ohyoung.bang@samsung.com braindoc@snu.ac.kr.
Abstract
BACKGROUND AND PURPOSE: The aim of the study was to assessed the impact of short-term exposure to air pollution on ischemic stroke subtype, while focusing on stroke caused via cardioembolism. METHODS: From a nationwide, multicenter, prospective, stroke registry database, 13 535 patients with acute ischemic stroke hospitalized to 12 participating centers were enrolled in this study. Data on the hourly concentrations of particulate matter <10 μm, nitrogen dioxide (NO2), sulfur dioxide (SO2), ozone (O3), and carbon monoxide (CO) were collected from 181 nationwide air pollution surveillance stations. The average values of these air pollutants over the 7 days before stroke onset from nearest air quality monitoring station in each patient were used to determine association with stroke subtype. The primary outcome was stroke subtype, including large artery atherosclerosis, small-vessel occlusion, cardioembolism, and stroke of other or undetermined cause. RESULTS: Particulate matter <10 μm and SO2 concentrations were independently associated with an increased risk of cardioembolic stroke, as compared with large artery atherosclerosis and noncardioembolic stroke. In stratified analyses, the proportion of cases of cardioembolic stroke was positively correlated with the particulate matter <10 μm, NO2, and SO2 quintiles. Moreover, seasonal and geographic factors were related to an increased proportion of cardioembolic stroke, which may be attributed to the high levels of air pollution. CONCLUSIONS: Our findings suggest that the short-term exposure to air pollutants is associated with cardioembolic stroke, and greater care should be taken for those susceptible to cerebral embolism during peak pollution periods. Public and environmental health policies to reduce air pollution could help slow down global increasing trends of cardioembolic stroke.
BACKGROUND AND PURPOSE: The aim of the study was to assessed the impact of short-term exposure to air pollution on ischemic stroke subtype, while focusing on stroke caused via cardioembolism. METHODS: From a nationwide, multicenter, prospective, stroke registry database, 13 535 patients with acute ischemic stroke hospitalized to 12 participating centers were enrolled in this study. Data on the hourly concentrations of particulate matter <10 μm, nitrogen dioxide (NO2), sulfur dioxide (SO2), ozone (O3), and carbon monoxide (CO) were collected from 181 nationwide air pollution surveillance stations. The average values of these air pollutants over the 7 days before stroke onset from nearest air quality monitoring station in each patient were used to determine association with stroke subtype. The primary outcome was stroke subtype, including large artery atherosclerosis, small-vessel occlusion, cardioembolism, and stroke of other or undetermined cause. RESULTS: Particulate matter <10 μm and SO2 concentrations were independently associated with an increased risk of cardioembolic stroke, as compared with large artery atherosclerosis and noncardioembolic stroke. In stratified analyses, the proportion of cases of cardioembolic stroke was positively correlated with the particulate matter <10 μm, NO2, and SO2 quintiles. Moreover, seasonal and geographic factors were related to an increased proportion of cardioembolic stroke, which may be attributed to the high levels of air pollution. CONCLUSIONS: Our findings suggest that the short-term exposure to air pollutants is associated with cardioembolic stroke, and greater care should be taken for those susceptible to cerebral embolism during peak pollution periods. Public and environmental health policies to reduce air pollution could help slow down global increasing trends of cardioembolic stroke.
Authors: Robin M Babadjouni; Drew M Hodis; Ryan Radwanski; Ramon Durazo; Arati Patel; Qinghai Liu; William J Mack Journal: J Clin Neurosci Date: 2017-05-18 Impact factor: 1.961